All Posts
Mass General Brigham Townhall Presentation
Mass General Brigham Innovation is maximizing the healthcare system’s growth strategy by investing in bold, transformative innovations and increasing commercialization opportunities. Watch an update from a recent system-wide townhall featuring Innovation team members Chris Coburn, Chief…
Read More
Innovation Discovery Grants Awarded to Mass General Brigham Scientific Advancements Designed to Help Patients, Healthcare Delivery
Six disruptive scientific advancements from Mass General Brigham have been awarded Innovation Discovery Grants (IDG) in the 2020 round of awards, as the highly competitive IDG program exceeds $3.5 million in grants since inception. Each of…
Read More
Our researchers receive global recognition
Clarivate Plc, a global leader in providing trusted information and insights to accelerate the pace of innovation, recently shared its list of Highly Cited Researchers™ 2020. This annual list identifies researchers who demonstrated significant influence in…
Read More
Investigators at Brigham and Women’s Hospital take active role in ACTIV-4
The COVID-19 virus has taken over life as we know it, creating a novel environment for science in which collaboration is key and extraordinary speed is expected without sacrificing accuracy. Funded through Operation Warp Speed, the…
Read More
Bayer Pharma Reflections on Innovation: Creating, Collaborating, and Accelerating Discovery During and After a Pandemic
At the 2020 World Medical Innovation Forum, Joerg Moeller, MD, PhD reflected on how Bayer is weathering the organizational challenges posed by the COVID-19 pandemic. Moderated by Janet Wu of Bloomberg, this fireside chat covered possible…
Read More
2020 COVID-19 White Paper
The long-term impacts of COVID-19 on healthcare, society and the economy are only beginning to reveal themselves. More than a thousand experts provide their thoughts on what’s ahead. We’re pleased to share the following analysis. Download…
Read More
Digital Health Becomes a Pillar: Tools, Payment, Data
Deployed in the crucible of the coronavirus pandemic, digital health has now become an essential pillar in the delivery of care. Alistair Erskine, MD of Mass General Brigham, Adam Landman, MD of Brigham Health, Brooke LeVasseur…
Read More
Massachusetts Eye and Ear Enters Licensing Agreement with Biogen to Develop Treatment for Inherited Retinal Disorder
Mass General Brigham Innovation Fund Licensing Agreement with Biogen to Focus on Developing Treatment for Inherited Retinal Degeneration Due to Mutations in the PRPF31 Gene July, 2, 2020: (BOSTON) – Massachusetts Eye and Ear, a member…
Read More
COVID-19: Technology Solutions Now and in the Future
At the 2020 World Medical Innovation Forum, experts leading large teams at the epicenter of the coronavirus outbreak discussed how technology is shaping the pandemic response today and in the coming years. In this panel, Stéfane…
Read More
Care in the Next 18 Months- Routine, Elective, Remote
Care in the Next 18 Months- Routine, Elective, Remote At the 2020 World Medical Innovation Forum, hospital chief executives reflected on how health care will evolve over the next 18 months in the face of COVID-19.…
Read More
The 2020 Disruptive Dozen
TOP 12 DISRUPTIVE HEALTHCARE TECHNOLOGIES Mapping spread of infectious diseases and reducing health disparities top list Mass General Brigham announced its selections for the sixth annual “Disruptive Dozen,” the 12 emerging clinical and artificial intelligence technologies…
Read More
Massachusetts Eye and Ear and Massachusetts General Hospital Advancing Novel Experimental Gene-based COVID-19 Vaccine, AAVCOVID
Massachusetts Eye and Ear and Massachusetts General Hospital (MGH) today announced progress towards the testing and development of an experimental vaccine called AAVCOVID, a novel gene-based vaccine candidate against SARS-CoV2, the virus that causes COVID-19. The…
Read More
Realizing the Promise of AI in the Clinic
The gap between the development of AI and its use and integration in the clinic is closing, as technology, sophisticated algorithms, data sets, and computational capacity are now directly supporting both clinicians and patient care in…
Read More
How Does My Idea Fit Into a Commercial Landscape?
Medical research can be an electrifying experience as novel ideas are turned into life-altering solutions. On the other hand, research can also be incredibly frustrating, especially when your work has reached a desired result, yet, you’re not certain…
Read More
From the Lab to the Clinic: Hasan Ready to Translate Her Photodynamic Research Into Patient Care
After nearly four decades of developing light-based technologies for treating disease at Massachusetts General Hospital (MGH), Tayyaba Hasan, PhD is excited about the potential to turn her discoveries into new treatments for patients. “We’re at a…
Read More
A Q&A with Roger Kitterman
How do these new funds enhance the Partners Innovation Fund? These funds extend the capabilities we built with PIF. TIF will allow us to invest in technologies at an earlier stage within our system and drive…
Read More
New Imaging Tools Could Reduce the Deadly Toll of Thrombus and Fibrosis
Diseases related to thrombus and fibrosis are a key contributor to strokes, heart attacks, organ failure and death and result in billions of dollars in healthcare costs each year. Thrombus—the formation of blot clots—is the most…
Read More
Acquisitions and Successful Financing Add to the Success of the Partners Innovation Fund
The Partners Innovation Fund (PIF) continues to add to their success in moving therapeutic strategies developed within the Partners HealthCare System (PHS) further down the development pipeline. Several recent deals and series A financing rounds support…
Read More